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ABSTRACT 
 
Aim of Study: To optimize a triplex real-time PCR assay developed elsewhere and to evaluate the 
performance characteristics of two different multi-channel real-time PCR systems on the newly 
optimized assay. 
Methodology: A triplex real-time PCR assay developed for three key genes encoding virulence 
and antibiotic resistance in Staphylococcus aureus, namely, lukSF-PV, mecA, and spa was 
optimized and evaluated using two different real-time PCR instruments (7500SDS and LightCycler 
480). Bacterial strains (N=230), including staphylococcal and non-staphylococcal isolates, were 
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used for the study. 
Results: Following optimization, cycling and data analysis completed within one hour compared 
with the former three hours. Assay specificity became 100% on both instruments. The negative 
predictive value (NPV) and the positive predictive value (PPV) rose to 100%.  
Conclusion: The optimized triplex real-time PCR assay is highly reproducible across the two 
systems without loss of speed, sensitivity and specificity. The results also suggested that user-
familiarization with each machine operational system would allow assay performance across 
various real-time PCR platforms currently being used. 
 
 
Keywords: Molecular diagnostics; instrumentation; real-time PCR; MRSA; PVL. 
 
1. INTRODUCTION 
 
Public health challenges from Staphylococcus 
aureus are associated with molecules which 
cause therapy refractory conditions. The 
molecules include staphylococcal proteinA (Spa) 
encoded by spa gene, penicillin-binding protein 
2a encoded by mecA gene, and Panton–
Valentine leucocidin (PVL) encoded by phage-
borne bi-component lukSF-PV operon [1]. Spa, 
coagulase and PVL have been incriminated in 
diverse S. aureus infections including abscesses, 
skin and soft tissue infections and musculo-
skeletal damage [2-4], while mecA-driven 
methicillin resistant S. aureus (MRSA) is of 
massive diagnostic, therapeutic and infection 
control importance. Whereas MRSAs first 
emerged in UK hospital patients [5,6], victims of 
PVL-associated disease are often young and 
otherwise healthy persons and outcome is 
usually independent of hospitalization and 
staphylococcal methicillin resistance status [7]. 
The convergence of virulence and antibiotic-
resistance signals high-level therapy refractory 
infections and more significant threat than the 
two factors separately [8]. 
 
Bacteriological culture-based tests for 
staphylococcal methicillin resistance take ≥24hrs. 
One of the diagnostic challenges from the 
convergence of rapidly mortifying PVL-
associated toxicity and methicillin resistance is 
that there is currently no reliable bacteriological 
assay for PVL. It has been suggested that 
application of multiplex PCR to detect multiple 
genetic markers within the same sample will 
enhance molecular diagnostics [9]. In line with 
this, several multiplexed assays have been 
developed in conventional and real-time PCR 
platforms, some of which have been reported to 
be ineffectual following evaluation studies. A 
recent evaluation revealed discrepancies 
between a triplex real-time PCR assay for nuc, 
pvl, and mecA [10] and phenotypic antimicrobial 
susceptibility testing (AST) which led to 
modification of the same triplex assay into a 
quadruplex assay [11]. To enable application 
across instruments and to keep performance at 
par with recent PVL-MRSA assays, we optimized 
a similar triplex real-time PCR assay for 
detection of spa, lukSF-PV and mecA [12]. Here 
we report the performance evaluation outcomes 
using two different multi-channel real-time PCR 
instruments. 
 
2. MATERIALS AND METHODS 
 
To enable application across instruments and to 
keep performance at par with recent assays for 
MRSA and PVL, the cycling conditions and 
reaction factors of a triplex real-time PCR assay 
originally described elsewhere [12] were 
optimized. Two real-time PCR instruments (ABI 
7500SDS: Applied Biosystems, CA, USA and 
LightCycler™ 480: Roche, Germany) were used 
for the study. Staphylococcal type culture strains 
(n=50) used for this study are listed (Table 1). 
The assay was further evaluated using randomly 
selected local clinical staphylococcal strains (n = 
121) isolated in the Nottingham area during the 
period August 2003 to December 2004 from 
blood, sputum, pleural effusion, cerebrospinal 
fluid (CSF), breast fluid, spinal fluid, wound 
swab, vaginal swab, abscess, urine and other 
specimens analysed by the Queen’s Medical 
Centre (QMC) microbiology laboratory. The 
above 171 strains were collected and stored      
(-80°C) by Dr. Richard Spence who used them 
for validation of microarrays [13]. Additional S. 
Aureus strains (n=17) and other staphylococci 
(n=20) were also used for the evaluation 
including S. capitis, S. sciuri, S. hemolyticus, S. 
saprophyticus, S. lugdunensis and S. 
epidermidis. Non-staphylococcal bacterial 
strains/DNA (n=22) including Escherichia coli, 
Group A Streptococcus, Pseudomonas spp., 
Proteus spp., and Klebsiella spp. were also used 
for performance evaluation. Thus, a total of 230 
DNA samples from bacteria were used for the 
evaluation. Extraction of DNA from the bacterial 
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isolates was performed by boiling and 
centrifugation as described elsewhere [14]. 
 
All primers were supplied by Sigma (Sigma 
Genosys, Cambridge, UK).Probes used on the 
AB7500 were exactly the same as published by 
Nakagawa and were purchased from Applied 
Biosystems (Applied Biosystems, Warrington, 
UK). The LCR670 probe used for the detection of 
mecAon the LC480 (Table 2) was purchased 
from TIB MOLBIOL (TIB MOLBIOL, Berlin, 
Germany). Manufacturer-specific master-mixes 
for the two instruments were used. To evaluate 
the specificity of the optimized assay, 
sequencing followed by standard nucleotide 
BLAST were used to confirm the identity of the 
PCR amplification products. Antibiotic 
susceptibility test (AST) was performed for 
staphylococcal oxacillin susceptibility. Tube 
coagulase (TC) test was used to confirm S. 
aureus. Ten-fold serial dilutions were performed 
on 0.5MacFarland standardized inoculum to 
determine the limit of detection (LoD) of the 
optimized assay. Bacterial DNA was extracted 
from each dilution and used for real-time PCR 
assay. 
 
2.1 Statistical Analysis 
 
The R
2 
values were calculated from the mean of 
five most linear points, an approach which 
increases the accuracy of the DNA quantification 
by allowing the real-time PCR software to 
perform a five-point standard curve [15]. 
Sensitivity, specificity, negative predictive value 
(NPV) and positive predictive value (PPV) of the 
triplex real-time PCR assay were analysed 
according to the Clinical and Laboratory 
Standards Institute (CLSI) Guidelines for 
molecular diagnostics [16]. 
 
3. RESULTS  
 
The optimized PCR cycling conditions which 
increased assay speed on both instruments and 
without spectral cross-talk consists of an initial 
single cycle for 5 minutes at 95ºC (to activate the 
polymerase system) and 40 cycles of two-
temperature cycling consisting of 15s at 95ºC (for 
denaturation) and 5s at 60ºC (for 
polymerization). The optimized triplex real-time 
PCR assay completed one diagnostic cycle 
including data analysis within one hour. This is a 
major speed advantage over the original assay 
by Nakagawa et al. [12]. In addition to the 
optimized PCR cycling conditions, the 
oligonucleotide primer–probe sets driving the 
triplex real-time PCR assay are listed (Table 3). 
Other optimized PCR factors which necessarily 
removed spectral cross-talk are also presented 
(Table 4). When the crossing point (Cp) values 
were plotted against the log10 of the bacterial 
DNA load, a good linearity was observed over 
the range from 1.0-2.0 x10
8
 colony forming 
units/ml (abbreviated: CFU/ml), which was 
confirmed phenotypically by serial dilution 
methods. This sensitivity result applied to both 
instruments. 
 
Using MRSA strains from NARSA to study assay 
specificity in monoplexes and multiplexes 
including NRS194, NRS192, and S. 
aureusUSA400 (MW2) whose genomes harbour 
all the three key genes, the assay reliably 
identified spa, lukSF-PV and mecA on both 
instruments. PVL-negative MSSA strains 
generated only the spa signal, PVL-positive 
MSSA strains yielded positive signals for spa and 
lukSF-PV, while producing negative signal for 
mecA. Methicillin-resistant coagulase-negative 
staphylococci (MRCoNS) including S. 
epidermidis strain NRS8, S. hemolyticus NRS9 
and S. epidermidis NRS69 all gave positive 
signals for mecA and and not for spa and lukSF-
PV. Also the 22 bacterial strains of non-
staphylococcal background generated no 
amplification signal with the triplex PCR assay. 
 
When we evaluated the triplex real-time PCR 
assay on direct bacterial cultures from frozen 
stocks, agar plates, and from 0.5McFarland broth 
used for phenotypic identification and AST, they 
all yielded concordant gene detection results. 
Despite differences in user interface and display 
of emission signals (Fig. 1), discordant 
performance characteristics were not found 
between the two instruments.  
 
4. DISCUSSION 
 
Optimization of the cycling conditions which led 
to completion of cycling and data analysis under 
one hour. This compares favourably with a 
recent real-time PCR assay reported by Pichon 
et al. [11]. Interestingly, the Pichon assay was 
developed following evaluation of a similar 2005 
triplex real-time PCR assay [10] which the 
Pichon group found erroneous that they modified 
and upgraded it to a quadruplex assay. The 
reduction in assay cycling time from 3 hours to 
less than one hour will empower microbiology 
laboratories to provide speedier diagnostic 
service. This will help reduce the rapid victim 
deterioration associated with therapy-refractory 
S. aureus PVL syndrome. 
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Table 1. Reference staphylococcal strains (n = 50) and their sources 
 
S/N Isolate identity
a
 Nomenclature (species level)  Source 
1 NRS1 S. aureus NARSA
b
 
2 NRS102 S. aureus NARSA 
3 NRS103 S. aureus NARSA 
4 NRS110 S. aureus NARSA 
5 NRS111 S. aureus NARSA 
6 NRS112 S. aureus NARSA 
7 NRS113 S. aureus NARSA 
8 NRS114 S. aureus NARSA 
9 NRS123 S. aureus NARSA 
10 NRS13 S. aureus NARSA 
11 NRS147 S. aureus NARSA 
12 NRS149 S. aureus NARSA 
13 NRS153 S. aureus NARSA 
14 NRS157 S. aureus NARSA 
15 NRS158 S. aureus NARSA 
16 NRS162 S. aureus NARSA 
17 NRS164 S. aureus NARSA 
18 NRS165 S. aureus NARSA 
19 NRS167 S. aureus NARSA 
20 NRS170 S. aureus NARSA 
21 NRS171 S. aureus NARSA 
22 NRS172 S. aureus NARSA 
23 NRS176 S. aureus NARSA 
24 NRS179 S. aureus NARSA 
25 NRS182 S. aureus NARSA 
26 NRS185 S. aureus NARSA 
27 NRS188 S. aureus NARSA 
28 NRS191 S. aureus NARSA 
29 NRS192 S. aureus NARSA 
30 NRS194 S. aureus NARSA 
31 NRS227 S. aureus NARSA 
32 NRS229 S. aureus NARSA 
33 NRS231 S. aureus NARSA 
34 NRS233 S. aureus NARSA 
35 NRS244 S. aureus NARSA 
36 NRS248 S. aureus NARSA 
37 NRS249 S. aureus NARSA 
38 NRS255 S. aureus NARSA 
39 NRS260 S. aureus NARSA 
40 NRS265 S. aureus NARSA 
41 NRS70 S. aureus NARSA 
42 NRS71 S. aureus NARSA 
43 NRS72 S. aureus NARSA 
44 NRS8 S. epidermidis NARSA 
45 NRS9 S. haemolyticus NARSA 
46 NRS69 S. haemolyticus NARSA 
47 NCTC12217 S. lugdunensis NCTC
c
 
48 NCTC11042 S. haemolyticus NCTC 
49 NCIMB9993 S. epidermidis NCIMBd 
50 NCIMB700787 S. capitis NCIMB 
a Identity of isolate at source, b NARSA, Network for Antimicrobial resistance in Staphylococcus aureus 
c NCTC, National Collection of Type Cultures, d NCIMB, National Collection of Industrial and Marine Bacteria 
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Table 2. Emission wavelengths of DNA probe fluorophores and channels used for detection of 
bacterial DNA on ABI 7500 and LC480 instruments 
  
DNA probe fluorophore Emission channel  Wavelength(nm) on 
ABI 7500 
Wavelength(nm) on 
LC480 
6FAM FAM 500 (FAM)  533 (FAM) 
VIC VIC/HEX 560 (VIC) 568 (HEX) 
TET/LCR670 TET/Cy5 530 (TET) 670 (LCR670) 
 
Table 3. Primer-probe sets used for evaluation of performance on both instruments
a 
 
Target 
sequence 
Amplicon 
size (bp) 
Primer and 
probe 
identity
b
 
Primer and probe
c
sequence 5'  →  3'   
mecA 155 mecA-F TGGTATGTGGAAGTTAGATTGGGAT 
mecA-P 
c
F-TTCCAGGAATGCAGAAAGACCAAAGCA-BBQ
d
 
mecA-R CTAATCTCATATGTGTTCCTGTATTGGC 
lukSF-PV 118 lukSF-PV-F TTACACAGTTAAATATGAAGTGAACTGGA 
lukSF-PV-P FAM-AAGTGAAAGGACATAATTG-MGBNFQ
e
 
lukSF-PV-R AGCAAAAGCAATGCAATTGATG 
spa 101 spa-F CAGCAAACCATGCAGATGCTA 
spa-P VIC-TCAAGCATTACCAGAAAC-MGBNFQ 
spa-R CGCTAATGATAATCCACCAAATACA 
a Primer and probe oligonucleotide sequences are all copied from Nakagawa et al. [12]. 
b F = forward primer; P = Probe; R = Reverse primer. c the 5′-end of the probe was labelled with TET for use with 
ABI 7500, while the 5′-end of the probe was labelled with LightCycler®Red 670 (LCR670) for use with LC480.d 
the 3′-end was labelled with a blackberry quencher. e the 3′-end of the probe was labelled with a minor groove 
binder molecule and non-fluorescent quencher (MGB-NFQ) 
 
 
 
Fig. 1. User interface output display of fluorescence signals for 50 cycles by ABI 7500SDS (A) 
and LC480 (B) 
 
Sensitivity and good linearity over the range 1.0-
2.0x10
8 
CFU/ml suggests the optimized triplex 
real-time PCR assay is of comparable sensitivity 
as the original assay developed by Nakagawa 
using a different machine (AB7900HT). 
Therefore the gain in speed associated with the 
newly optimized assay was without loss of 
sensitivity. PCR was commended by early 
experimenters for its sensitivity [17]. Also, the 
fact that no amplification signal was detected 
from the 22 non-staphylococcal bacteria 
examined with the optimized triplex real-time 
PCR assay shows the assay did not lose 
specificity (precision and accuracy) following 
optimization.  
 
c
b
a
A B
c
a
b
d
c
A
 
 
 
 
Okolie and James; JALSI, 2(4): 145-151, 2015; Article no.JALSI.2015.016 
 
 
 
150 
 
The newly optimized triplex real-time PCR assay 
identified all mecA-positive oxacillin resistant 
strains, including high-level (MIC oxacilin ≥32 
g/L) and very low-level (0.5 g/L) expressors. The 
assay also detected mecA gene from all the 
SCCmec types collected by Dr Spence, including 
those local to Nottingham as well as the National 
(NCTC and NCIMB) and  international (NARSA) 
type culture strains. Thus, the capacity of the 
optimized real-time PCR assay to detect the 
expected gene sequences as confirmed by 
sequencing and BLAST was 100%. This 
represents a 100% positive predictive value 
(PPV=100%). Evaluation of a similar assay 
developed in 2005 [10] showed it was unable to 
detect some SCCmec types which encoded 
phenotypically confirmed oxacillin resistance 
[11]. Also, the 22 eubacteria of non-
staphylococcal background yielded no 
amplification signal, representing a negative 
predictive value (NPV) of 100%. Other than 
obvious differences in the user interface and 
signal output style (Fig. 1), there was no 
difference in speed between the two instruments.  
 
Table 4. PCR factors of the optimized triplex 
real-time PCR assay 
 
Factor  Quantity 
Probe mastermix 25.0 µL 
spa and lukSF-PV primers  0.75 µM 
mecA  primers 1.0 µM 
spa probe  0.04 µM 
lukSF-PV probe  0.08 µM 
mecA probe 0.1 µM 
PCR grade water (Roche) Make up to 50.0 µL 
 
The difference between R
2
 values reported by 
Nakagawa who used ABI 7900HT and the R
2
 
values we obtained in this evaluation using two 
different instruments were not significant (<0.01, 
Student's t test: p=0.99). Thus the analytical 
quantitative essence of the triplex real-time PCR 
assay is highly reproducible on both instruments. 
 
Quantification of input DNA is very important in 
real-time PCR and constitutes a major advantage 
of real-time PCR over end-point PCR. This is 
especially important when quantifying input 
template DNA in clinical samples.   
 
5. CONCLUSION 
 
NPV and PPV values of 100% suggest that the 
triplex real-time PCR assay is capable of 
confirming or ruling out the presence of the three 
key genes in a given bacterial isolate. Thus, the 
primer–probe sets for lukSF-PV, mecA and spa 
yielded 100% gene detection specificity on both 
instruments. The sensitivity, speed, specificity 
and reproducibility generated from using the 
triplex real-time PCR assay on both instruments 
show the assay is readily adaptable for use in a 
routine diagnostic microbiology laboratory across 
different instruments. The sensitivity and 
specificity of the assay on direct detection from 
broths and colony PCR suggests the applicability 
of the assay for direct detection of the three key 
genes from biological samples. Completion of 
cycling and data analysis under an hour means 
the optimized assay is speedy enough to support 
timely infection control and clinical therapeutic 
interventions than would be possible by 
conventional microbiological culture-based 
assays. 
 
Despite difference in signal detection emission 
channels, the triplex real-time PCR assay 
developed using one machine had been 
packaged and operated on another real-time 
PCR proprietary instrument(s) from a completely 
different manufacturer. What is required is sound 
understanding of the operational style of each 
unique instrument, including the wavelengths for 
the different emission channels as well as the 
output signal and the user-interface data 
presentation style. 
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